Liposomes loaded with rifampicin and tobramycin for anti-staphylococcus aureus action

Mauris N. DeSilva, William W. Zhao, Kyumin Whang, Stephen T. Schultz, Lianrui Chu

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Scopus citations

Abstract

Reducing patient recovery time and potential post surgical complications of warfighters after traumatic injury is of importance for the military. However, a current medical challenge in treating warfighters with traumatic injuries is bacterial infection due to multi-drug resistant bacteria. These infections can delay wound healing and increase the rate of mortality in severe cases of infections. We are developing a nanosystem that preserves functionality and controls delivery of antibiotics for an extended period of time. This system is expected to exert antibacterial activity for a broad spectrum of bacterial species. In this study, we investigated the particle size, entrapment efficiency, and antibacterial activities of two antibiotics, rifampicin and tobramycin, [active against Staphylococcus aureus (S.a, ATCC 12600) and Methicillin-resistant strain of S.a (MRSA, BAA-1720)] in liposomes synthesized by a modified dehydration-rehydration liposome method. Encapsulation efficiency of liposomes decreased with decrease in drug concentration, and was also affected by the type of drug encapsulated. For rifampicin, initial drug loadings of 20 mg, 10 mg, 5 mg and 2.5 mg resulted in entrapment efficiencies of 64.8 ± 17.3%, 49.6 ± 1.9, 39.2 ± 9.7%, and 36.9 ± 5.9%, respectively, and for tobramycin entrapment efficiencies were 26.7 ± 4.7%, 24.3 ± 5.3% and 22.5 ± 3.5% and 19.4 ± 3.7%, respectively. The average particle sizes of liposomes in the mixture was approximately 200-300 nm and 300-500 nm for tobramycin and rifampicin, respectively, and they also varied depending on the amount of drug that was used for liposome synthesis. In vitro antibiotic release studies were performed for 7-9 days in phosphate-buffered saline (PBS) at 37°C. The results demonstrated that liposomes released sufficient amount of antibiotics, and antibacterial activities were preserved over this period against S.a. Currently, we are investigating a variety of ways to incorporate these liposome systems into various antimicrobial agent delivery systems.

Original languageEnglish (US)
Title of host publicationTechnical Proceedings of the 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011
Pages298-301
Number of pages4
StatePublished - Nov 23 2011
EventNanotechnology 2011: Electronics, Devices, Fabrication, MEMS, Fluidics and Computational - 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011 - Boston, MA, United States
Duration: Jun 13 2011Jun 16 2011

Publication series

NameTechnical Proceedings of the 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011
Volume3

Other

OtherNanotechnology 2011: Electronics, Devices, Fabrication, MEMS, Fluidics and Computational - 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011
CountryUnited States
CityBoston, MA
Period6/13/116/16/11

ASJC Scopus subject areas

  • Bioengineering
  • Biomedical Engineering
  • Electrical and Electronic Engineering

Fingerprint Dive into the research topics of 'Liposomes loaded with rifampicin and tobramycin for anti-staphylococcus aureus action'. Together they form a unique fingerprint.

  • Cite this

    DeSilva, M. N., Zhao, W. W., Whang, K., Schultz, S. T., & Chu, L. (2011). Liposomes loaded with rifampicin and tobramycin for anti-staphylococcus aureus action. In Technical Proceedings of the 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011 (pp. 298-301). (Technical Proceedings of the 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011; Vol. 3).